Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic Vulnerabilities
Authors:
Open Access
- 6 November 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-21
Abstract
RNA splicing dysregulation has emerged as a hallmark of cancer and a promising therapeutic target; however, its full landscape in human solid cancer remains poorly characterized. To address this, we perform alternative splicing analyses using RNA-sequencing data from 751 lung adenocarcinoma samples from our cohort integrated with 519 samples from The Cancer Genome Atlas. Visualization of splicing patterns using t-distributed stochastic neighbor embedding reveals substantial inter-tumor heterogeneity driven by distinct molecular subtypes and histological differentiation. We identify a unique molecular subtype associated with inactivating mutations in CMTR2 , which encodes Cap-specific mRNA (nucleoside-2’-O-)-methyltransferase 2. CMTR2 mutations are observed in 3.8% of cases and are predominantly truncating mutations, which form an isolated cluster within the splicing landscape. Intrinsic and CRISPR-Cas9-engineered CMTR2 mutations disrupt alternative splicing and sensitize cancer cells to sulfonamide-based RNA splicing modulators and immune checkpoint blockade therapy. Retrospective patient data confirm the increased sensitivity of CMTR2 -deficient tumors to immune checkpoint blockade therapy. These findings uncover a previously unrecognized RNA splicing deficiency in human cancers and define a molecular subtype of lung adenocarcinoma driven by RNA splicing dysregulation, suggesting targets for therapeutic intervention in lung cancer.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP23ak0101205, JP24ama221233, JP24ck0106905)
- MEXT | Japan Society for the Promotion of Science (25K02539, 22KJ3158, 20H00545)
- Research Grant of the Princess Takamatsu Cancer Research Fund
- MEXT | Japan Science and Technology Agency (JPMJCR1689, JPMJCR18Y4)
This publication has 115 references indexed in Scilit:
- Quantification of Propargylated RNA Nucleosides After Metabolic Labeling Via the Methylation PathwayChemBioChem, 2025
- Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancerBioorganic Chemistry, 2024
- New parallel computing algorithm of molecular dynamics for extremely huge scale biological systemsJournal of Computational Chemistry, 2020
- Targeting an RNA-Binding Protein Network in Acute Myeloid LeukemiaCancer Cell, 2019
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 PatientsCancer Cell, 2018
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerCancer Cell, 2018
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel SequencingCell, 2012
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- General atomic and molecular electronic structure systemJournal of Computational Chemistry, 1993